万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 运输方式:
冻存运输
- 细胞形态:
上皮样
- 生长状态:
贴壁生长
- 库存:
大量
- 年限:
newborn
- 相关疾病:
正常
- ATCC Number:
CRL-2007™
- 器官来源:
皮肤
- 物种来源:
小鼠
- 是否是肿瘤细胞:
0
- 组织来源:
epidermis
- 品系:
BALB/c
| Designations: | JB6 Cl 30-7b | ||
| Depositors: | NH Colburn | ||
| Biosafety Level: | 1 | ||
| Shipped: | frozen | ||
| Medium & Serum: | See Propagation | ||
| Growth Properties: | adherent | ||
| Organism: | Mus musculus | ||
| Morphology: | epithelial |
||
| Source: | Organ: skin Strain: BALB/c Tissue: epidermis Disease: normal |
||
| Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | ||
| Tumorigenic: | No | ||
| Age: | newborn | ||
| Comments: | This is one of several lines that are useful in studies of the molecular events in tumor promotion and for development of promotion assays (see also ATCC CRL-2002 - RT101, ATCC CRL-2010 - JB6 Cl 41-5a and ATCC CRL-2012 - T36274). The JB6 Cl 30-7b cell line was derived from primary cultures of neonatal BALB/c epidermal cells that had been treated with dimethylsulfoxide (DMSO, 0.01 to 0.1 %). The line is resistant to promotion of transformation (P-) by phorbol esters. These cells can be used in comparisons with P+ cells for studying differential responses to tumor promoters. Never allow the cells to become confluent. The cells must be carried at low density to avoid spontaneous transformation. |
||
| Propagation: | ATCC complete growth medium: Minimum essential medium (Eagle) with 2 mM L-glutamine, 95%; fetal bovine serum, 5% Temperature: 37.0°C |
||
| Subculturing: | Protocol: The cells must be carried at low density to avoid spontaneous transformation.Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. 1. Remove and discard culture medium.2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting. 5. Add appropriate aliquots of the cell suspension to new culture vessels. An inoculation density of 2 x 104 viable cells per 25 sq. cm. flask is recommended or a spilt ratio of 1:6 to 1:8.6. Incubate cultures at 37�C. Subcultivation Ratio: An inoculation density of 2 X 10 exp4 viable cells per 25 sq. cm. flask is recommended Medium Renewal: 1 to 2 times per week Rap the flask smartly against a hard surface to get a single cell suspension. Add fresh medium, aspirate and dispense into new flasks. Culture at 36C in a humidified atmosphere of 5% CO2 - 95% air. |
||
| References: | 22309: Colburn NH, et al. A cell culture assay for tumor-promoter-dependent progression toward neoplastic phenotype: detection of tumor promoters and promotion inhibitors. Teratog. Carcinog. Mutagen. 1: 87-96, 1980. PubMed: 6119803 22427: Colburn NH, et al. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38: 624-634, 1978. PubMed: 626967 22908: Colburn NH, et al. Tumour promoter induces anchorage independence irreversibly. Nature 281: 589-591, 1979. PubMed: 492322 22959: Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244: 566-569, 1989. PubMed: 2541502 23279: Colburn NH, et al. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc. Natl. Acad. Sci. USA 78: 6912-6916, 1981. PubMed: 6947266 |
||
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关专题 (一) 原理 葡萄球菌A蛋白(SPA)具有与多种哺乳动物 IgG分子Fc段结合的能力,并与不同IgG亚类的结合力有所差别。利用改变PH及离子强度可洗脱结合于SPA-Sepharose CL-4B柱上的IgG或不同的IgG亚类,可直接纯化血清或小鼠腹水中的IgG抗体。 (二) 操作步骤 用0.1M PH8.0 磷酸缓冲液 浸泡SPA-Sepharose CL-4B凝胶,15min。按1g干胶200ml
PREPARATION OF PROTEIN A SEPHAROSE CL 4B BEADS
so that the total volume of beads plus buffer is 2 ml).Blocking and Use1.Remove desired volume of 50% slurry (30 µl of slurry per I.P.or Chip).Put in 15 ml conical tube.2.Spin in table top3.Resuspend beads in cold blocking buffer:T. E.25 ml of T.E0.1% Azide25 µl
抗体纯化:SPA-sepharose cl-4b 亲合层析法
一、原理葡萄球菌a蛋白(SPA)具有与多种哺乳动物IgG分子fc段结合的能力,并与不同IgG亚类的结合力有所差别。改变pH及离子强度可洗脱结合于SPA-sepHarose cl-4b 柱上的IgG或不同的IgG亚类,可直接纯化血清或小鼠腹水中的IgG抗体。二、试剂器材1、spa-sepharose cl-4b (pharmacia-sigma)2、磷酸缓冲液0.1mol/l pH8.6+0.02% NaN33、枸橼酸缓冲液0.1mol/l pH5.5 0.1mol/l pH
技术资料暂无技术资料 索取技术资料





